Post by David Grey on Nov 21, 2017 12:14:22 GMT -5
The primary objective of this study is to evaluate the potential for a pharmacokinetic (PK) drug-drug interaction between ubrogepant and sumatriptan in healthy adult participants.
50 West 84Th Street
Miami, FL 33014-3616
(305) 817-8722
Sponsored By: Clinical Pharmacology of Miami
Stipend: $1400 - $1400
Length of Study: 6 weeks
Research Facility: In-Patient
Gender: Both
Age: 18 - 45
Health Condition: *Healthy Volunteers Studies
More Information: 3 confinement periods of 2 nights/3 days and 1 follow up visit over appmately 3 days.
view full study or go to Clin Pharm of Miami website: www.studyscavenger.com/SiteID/5ecae1a3-fc44-4f49-8329-c60ceb14e207/a--single-center--label-randomized-3-way-crossoverpharmacokinetic-interaction-study-between-ubro
50 West 84Th Street
Miami, FL 33014-3616
(305) 817-8722
Sponsored By: Clinical Pharmacology of Miami
Stipend: $1400 - $1400
Length of Study: 6 weeks
Research Facility: In-Patient
Gender: Both
Age: 18 - 45
Health Condition: *Healthy Volunteers Studies
More Information: 3 confinement periods of 2 nights/3 days and 1 follow up visit over appmately 3 days.
view full study or go to Clin Pharm of Miami website: www.studyscavenger.com/SiteID/5ecae1a3-fc44-4f49-8329-c60ceb14e207/a--single-center--label-randomized-3-way-crossoverpharmacokinetic-interaction-study-between-ubro